SCHEMBL15021

SCHEMBL15021

CC1(C)CCC(C)(C)C(=O)C1=O

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7548140 0.90 ACHE (0.40) ACHE
SCHEMBL7783627 0.90 TYMS (0.31)
SCHEMBL965199 0.86 ACHE (0.37) ACHE
SCHEMBL966903 0.86 ACHE (0.41) ACHE
SCHEMBL2458387 0.83 ACHE (0.40) ACHE
SCHEMBL968768 0.83 ACHE (0.35) ACHE
SCHEMBL8594481 0.81 ACHE (0.39) ACHE
SCHEMBL14615403 0.78 ALDH1A1 (0.35) RAB9ASMN1; SMN2
SCHEMBL2036437 0.77 KDM4E (0.33) RAB9ASMN1; SMN2
SCHEMBL2692984 0.77 KDM4E (0.31) RAB9ASMN1; SMN2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 880 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517666-B1 PROCESSES FOR FORMING DENTAL MATERIALS 3M INNOVATIVE PROPERTIES CO (US) 2010-11-17 EP claimed
US-7465758-B2 Dental compositions and methods with arylsulfinate salts 3M INNOVATIVE PROPERTIES COMPANY (US) 2008-12-16 US claimed
EP-1663115-B1 DENTAL COMPOSITIONS AND METHODS WITH ARYLSULFINATE SALTS 3M INNOVATIVE PROPERTIES CO (US) 2008-09-03 EP claimed
US-7381516-B2 Multiphoton photosensitization system 3M INNOVATIVE PROPERTIES COMPANY (US) 2008-06-03 US claimed
US-20080014560-A1 DENTAL COMPOSITIONS AND METHODS WITH ARYLSULFINATE SALTS 3M INNOVATIVE PROPERTIES COMPANY 2008-01-17 US claimed
US-7250452-B2 Dental compositions and methods with arylsulfinate salts 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-07-31 US claimed
US-7134875-B2 Processes for forming dental materials and device 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-11-14 US claimed
EP-1663115-A1 DENTAL COMPOSITIONS AND METHODS WITH ARYLSULFINATE SALTS 3M Innovative Properties Company (US) 2006-06-07 EP claimed
US-7005229-B2 Multiphoton photosensitization method 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-02-28 US claimed
EP-1552345-A2 MULTIPHOTON PHOTOSENSITIZATION METHOD 3M Innovative Properties Company (US) 2005-07-13 EP claimed
US-20030119931-A1 Novel spiroorthocarbonates THE CURATORS OF THE UNIVERSITY OF MISSOURI 2003-06-26 US claimed
US-6458865-B2 FOR DENTAL RESTORATION MATERIAL CURATORS OF THE UNIVERSITY OF MISSOURI 2002-10-01 US claimed
EP-1165627-A4 PHOTOPOLYMERIZABLE VINYL ETHER BASED MONOMERIC FORMULATIONS AND POLYMERIZABLE COMPOSITIONS WHICH MAY INCLUDE CERTAIN NOVEL SPIROORTHOCARBONATES UNIV MISSOURI (US) 2002-03-20 EP claimed
US-20020013380-A1 PHOTOPOLYMERIZABLE VINYL ETHER BASED MONOMERIC FORMULATIONS AND POLYMERIZABLE COMPOSITIONS WHICH MAY INCLUDE CERTAIN NOVEL SPIROORTHOCARBONATES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-01-31 US claimed
EP-1165627-A1 PHOTOPOLYMERIZABLE VINYL ETHER BASED MONOMERIC FORMULATIONS AND POLYMERIZABLE COMPOSITIONS WHICH MAY INCLUDE CERTAIN NOVEL SPIROORTHOCARBONATES THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) 2002-01-02 EP claimed
WO-2000042080-A1 PHOTOPOLYMERIZABLE VINYL ETHER BASED MONOMERIC FORMULATIONS AND POLYMERIZABLE COMPOSITIONS WHICH MAY INCLUDE CERTAIN NOVEL SPIROORTHOCARBONATES THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) 2000-07-20 WO claimed
US-6084004-A MIXTURES OF EPOXY COMPOUNDS, DIARYLIODINIUM COMPOUNDS, ALPHA-DICARBONYL COMPOUNDS, AROMATIC AMINES, FILLERS AND ADJUVANTS WHICH POLYMERIZE TO YIELD STRONG TRANSPARENT PLASTICS FOR DENTAL PROSTHETICS ESPE DENTAL AG (DE) 2000-07-04 US claimed
EP-0897710-A2 Light-initiated cationic curable compositions and their use ESPE Dental AG (DE) 1999-02-24 EP claimed
EP-0789721-A2 VISIBLE-LIGHT CURABLE EPOXY SYSTEM WITH ENHANCED DEPTH OF CURE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-08-20 EP claimed
WO-1996013538-A2 VISIBLE-LIGHT CURABLE EPOXY SYSTEM WITH ENHANCED DEPTH OF CURE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1996-05-09 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080014560-A1 DENTAL COMPOSITIONS AND METHODS WITH ARYLSULFINATE SALTS ARSA, EPN1, SUDS3 RAB9A 1980/4885SMN1; SMN2 3249/4885ACHE 4293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.